AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
-6.32%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.88B
AUM Growth
+$2.88B
(-25%)
Cap. Flow
-$344M
Cap. Flow
% of AUM
-11.96%
Top 10 Holdings %
Top 10 Hldgs %
76.21%
Holding
111
New
12
Increased
16
Reduced
18
Closed
9
Top Buys
| 1 |
RUBY
Rubius Therapeutics, Inc
RUBY
|
$69.8M |
| 2 |
Amicus Therapeutics
FOLD
|
$13.3M |
| 3 |
Alibaba
BABA
|
$10.7M |
| 4 |
NIO
NIO
|
$10.5M |
| 5 |
AnaptysBio
ANAB
|
$9.98M |
Top Sells
| 1 |
WW
WW International
WW
|
$432M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$15.6M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$12.9M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$9.04M |
| 5 |
Immunic
IMUX
|
$6.85M |
Sector Composition
| 1 | Healthcare | 61.03% |
| 2 | Consumer Discretionary | 37.81% |
| 3 | Technology | 0.32% |
| 4 | Financials | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Micron Technology
MU
$133B
| – | – | 0 | – | – |
|
102
Syndax Pharmaceuticals
SNDX
$1.41B
| – | – | -60,697 | Closed | -$426K |
|
103
Wells Fargo
WFC
$263B
| – | – | 0 | – | – |
|
104
Wave Life Sciences
WVE
$1.53B
| – | – | -100,000 | Closed | -$3.83M |
|
105
Wynn Resorts
WYNN
$13.2B
| – | – | 0 | – | – |
|
106
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|
|
ACGN
107
DELISTED
Aceragen, Inc. Common Stock
ACGN
| – | – | -2,750,000 | Closed | -$3.63M |
|
|
CLVS
108
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – | 0 | – | – |
|
|
GBT
109
DELISTED
Global Blood Therapeutics, Inc.
GBT
| – | – | -200,000 | Closed | -$9.04M |
|
|
SNNA
110
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
| – | – | -99,000 | Closed | -$1.5M |
|
|
CELG
111
DELISTED
Celgene Corp
CELG
| – | – | 0 | – | – |
|